Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Mar 25, 2008
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 500,000 $2.55
Mar 25, 2008
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 $2.55
Dec 06, 2007
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 $3.15
Dec 06, 2007
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $3.15
Dec 06, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 $3.15
Nov 26, 2007
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,000 $2.75
Nov 21, 2007
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 $2.72
Nov 21, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,772 $2.79
Nov 21, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 1,228 $2.70
Aug 01, 2007
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 $3.58
Aug 01, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 1,200 $3.60
Aug 01, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 2,200 $3.59
Aug 01, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 1,600 $3.58
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 20, 2007
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $6.90
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $6.90
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $6.90
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 20, 2007
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 75,000 --
Jul 20, 2007
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jul 20, 2007
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Jul 20, 2007
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 150,000 $6.90
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $6.90

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.